R

Rocket Pharmaceuticals

D
RCKT
USD
-0.88
(-5.6158%)
Market Closed
48,166.00
حجم التداول
-2.466
الربح لكل سهم
-
العائد الربحي
-5.339350
P/E
1,345,532,954.61
حجم السوق
اليوم
-5.6158%
1 اسبوع
-14.261%
1 شهر
-12.563%
6 اشهر
-36.768%
12 اشهر
-33.077%
بداية السنة
-50.552%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Rocket Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
هل تحتاج مساعدة او لديك استفسار؟